These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1500207)

  • 1. A conjugated synthetic peptide corresponding to the C-terminal region of Clostridium perfringens type A enterotoxin elicits an enterotoxin-neutralizing antibody response in mice.
    Mietzner TA; Kokai-Kun JF; Hanna PC; McClane BA
    Infect Immun; 1992 Sep; 60(9):3947-51. PubMed ID: 1500207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of multiple antigenic determinants of Clostridium perfringens enterotoxin as revealed by use of different synthetic peptides.
    Sugii S
    J Vet Med Sci; 1994 Dec; 56(6):1047-50. PubMed ID: 7535106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Adjuvant-Free Bivalent Food Poisoning Vaccine by Augmenting the Antigenicity of
    Suzuki H; Hosomi K; Nasu A; Kondoh M; Kunisawa J
    Front Immunol; 2018; 9():2320. PubMed ID: 30356722
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of a bivalent food poisoning vaccine: augmented antigenicity of the C-terminus of Clostridium perfringens enterotoxin by fusion with the B subunit of Escherichia coli Shiga toxin 2.
    Hosomi K; Hinenoya A; Suzuki H; Nagatake T; Nishino T; Tojima Y; Hirata SI; Matsunaga A; Kondoh M; Yamasaki S; Kunisawa J
    Int Immunol; 2019 Feb; 31(2):91-100. PubMed ID: 30329068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
    Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
    Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety of a mucosal vaccine using the C-terminal fragment of Clostridium perfringens enterotoxin.
    Suzuki H; Kakutani H; Kondoh M; Watari A; Yagi K
    Pharmazie; 2010 Oct; 65(10):766-9. PubMed ID: 21105580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region.
    Hanna PC; Mietzner TA; Schoolnik GK; McClane BA
    J Biol Chem; 1991 Jun; 266(17):11037-43. PubMed ID: 1645721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of an alanine-substituted mutant of the C-terminal fragment of Clostridium perfringens enterotoxin as a mucosal vaccine in mice.
    Suzuki H; Kondoh M; Kakutani H; Yamane S; Uchida H; Hamakubo T; Yagi K
    Biomaterials; 2012 Jan; 33(1):317-24. PubMed ID: 21983135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of functional regions of Clostridium perfringens type A enterotoxin.
    Hanna PC; Wieckowski EU; Mietzner TA; McClane BA
    Infect Immun; 1992 May; 60(5):2110-4. PubMed ID: 1373406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of monoclonal antibodies to Clostridium perfringens enterotoxin.
    Horiguchi Y; Uemura T; Kamata Y; Kozaki S; Sakaguchi G
    Infect Immun; 1986 Apr; 52(1):31-5. PubMed ID: 2870028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetically engineered vaccine against the alpha-toxin of Clostridium perfringens protects mice against experimental gas gangrene.
    Williamson ED; Titball RW
    Vaccine; 1993 Sep; 11(12):1253-8. PubMed ID: 8256506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody against Clostridium perfringens type A enterotoxin in healthy beef cattle and human populations in Brazil.
    Brant PC; Riemann HP; Franti CE; Torres-Anjel MJ
    Rev Latinoam Microbiol; 1978; 20(3):139-42. PubMed ID: 225770
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of enzyme linked immunosorbent assay (ELISA) in the quantitation of Clostridium perfringens type A enterotoxin and antienterotoxin antibodies.
    Narayan KG; Genigeorgis C; Behymer D
    Int J Zoonoses; 1983 Dec; 10(2):105-10. PubMed ID: 6327556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium perfringens enterotoxin-based protein engineering for the vaccine design and delivery system.
    Lan H; Hosomi K; Kunisawa J
    Vaccine; 2019 Sep; 37(42):6232-6239. PubMed ID: 31466706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine Clostridium perfringens type A spores, enterotoxin and antibody to enterotoxin.
    Estrada Correa AE; Taylor DJ
    Vet Rec; 1989 Jun; 124(23):606-10. PubMed ID: 2547268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a fusion protein carrying antigenic determinants of enteric clostridial toxins.
    Belyi IF; Varfolomeeva NA
    FEMS Microbiol Lett; 2003 Aug; 225(2):325-9. PubMed ID: 12951260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
    Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of monoclonal antibodies against Clostridium perfringens type A enterotoxin.
    Wnek AP; Strouse RJ; McClane BA
    Infect Immun; 1985 Nov; 50(2):442-8. PubMed ID: 2865210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular variation between the alpha-toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals.
    Ginter A; Williamson ED; Dessy F; Coppe P; Bullifent H; Howells A; Titball RW
    Microbiology (Reading); 1996 Jan; 142 ( Pt 1)():191-198. PubMed ID: 8581165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.